775118
硼烷二甲基硫醚络合物 溶液
1.0 M in 2-methyltetrahydrofuran
别名:
BMS, 三氢 [硫代双 [甲烷]] 硼
登录查看公司和协议定价
选择尺寸
关于此项目
线性分子式:
(CH3)2S · BH3
化学文摘社编号:
分子量:
75.97
Beilstein:
3663489
MDL编号:
UNSPSC代码:
12352112
PubChem化学物质编号:
NACRES:
NA.22
表单
liquid
质量水平
反应适用性
reagent type: reductant
环保替代产品特性
Safer Solvents and Auxiliaries
Use of Renewable Feedstocks
Inherently Safer Chemistry for Accident Prevention
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
浓度
1.0 M in 2-methyltetrahydrofuran
密度
0.844 g/mL at 25 °C
官能团
thioether
环保替代产品分类
, Aligned
储存温度
2-8°C
SMILES字符串
B.CSC
InChI
1S/C2H6S.BH3/c1-3-2;/h1-2H3;1H3
InChI key
RMHDLBZYPISZOI-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. This product, 1.0 M in 2-methyltetrahydrofuran aligns with "Safer Solvents and Auxiliaries", "Use of Renewable Feedstocks" and "Inherently Safer Chemistry for Accident Prevention". Find details here.
应用
用作区域选择性还原剂的反应物
涉及的反应物：
涉及的反应物：
- 硼氢化/氧化
Commonly used in hydroboration of olefins and as a reductant of carbonyls. 2-Me-THF has shown potential as an environmentally friendly solvent compared to commonly used solvents; e.g. dichloromethane and THF.
For an alternative to Tetrahydrofuran and Dichloromethane, please see: An alternative to Tetrahydrofuran and Dichloromethane
包装
The 25 mL Sure/Seal™ bottle is recommended as a single-use bottle. Repeated punctures will likely result in decreased performance of product.
法律信息
Sure/Seal is a trademark of Sigma-Aldrich Co. LLC
警示用语：
Danger
危险分类
Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 2 - Repr. 1B - Skin Irrit. 2 - Water-react 1
补充剂危害
储存分类代码
4.3 - Hazardous materials which set free flammable gases upon contact with water
WGK
WGK 2
闪点(°F)
9.3 °F
闪点(°C)
-12.6 °C
法规信息
危险化学品
此项目有
Marieke M ter Wee et al.
Annals of the rheumatic diseases, 74(6), 1233-1240 (2014-05-14)
Recently, we documented the likely non-inferiority of Combinatietherapie Bij Reumatoïde Artritis (COBRA)-light therapy (methotrexate increased to 25 mg/week with initial prednisolone 30 mg/day) compared with the original COBRA therapy (methotrexate 7.5 mg/week, sulfasalazine 2 g/day, with initial prednisolone 60 mg/day) after 26 weeks in patients with
D J Hunter et al.
Osteoarthritis and cartilage, 23(5), 732-746 (2015-05-09)
Tremendous advances have occurred in our understanding of the pathogenesis of hand osteoarthritis (OA) and these are beginning to be applied to trials targeted at modification of the disease course. The purpose of this expert opinion, consensus driven exercise is
Pei-Chun Chen et al.
PloS one, 10(4), e0125257-e0125257 (2015-04-30)
Data on the use of oral anticoagulation (OAC) and antiplatelet therapy and the risk of bleeding and stroke amongst Asian patients with atrial fibrillation (AF) are limited. We investigated the risks of bleeding and stroke with use of oral anticoagulation
John M Kane et al.
The Journal of clinical psychiatry, 76(3), 240-246 (2015-04-02)
The premise of the National Institute of Mental Health Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE-ETP) is to combine state-of-the-art pharmacologic and psychosocial treatments delivered by a well-trained, multidisciplinary team in order to significantly improve the functional
Kathleen C Rollet-Kurhajec et al.
PloS one, 10(6), e0129868-e0129868 (2015-06-20)
In Hepatitis C virus (HCV) mono-infection, male sex is associated with faster liver fibrosis progression but the effects of sex have not been well studied in HIV-HCV co-infected patients. We examined the influence of sex on progression to significant liver
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持